Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Astellas Pharma Long-Term Investments 2012-2024 | ALPMY

Astellas Pharma long-term investments from 2012 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  
Astellas Pharma Annual Long-Term Investments
(Millions of US $)
2024 $824
2023 $831
2022 $835
2021 $928
2020 $724
2019 $767
2018 $666
2017 $577
2016 $762
2015 $1,020
2014 $940
2013 $666
2012 $745
2011 $0
2010 $0
2009 $0
Astellas Pharma Quarterly Long-Term Investments
(Millions of US $)
2024-06-30 $851
2023-06-30 $807
2022-06-30 $816
2021-06-30 $906
2020-06-30 $808
2019-06-30 $786
2018-06-30 $781
2017-06-30 $565
2016-09-30 $836
2016-06-30 $776
2016-03-31 $762
2015-12-31 $884
2015-09-30 $777
2015-06-30 $870
2015-03-31 $1,020
2014-12-31 $943
2014-09-30 $880
2014-06-30 $912
2014-03-31 $940
2013-12-31 $722
2013-09-30 $650
2013-06-30 $655
2013-03-31 $666
2012-12-31 $708
2012-09-30 $751
2012-06-30 $754
2012-03-31 $745
2011-12-31 $725
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $12.558B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.521B 32.46
Zoetis (ZTS) United States $69.359B 25.88
Takeda Pharmaceutical (TAK) Japan $47.920B 9.53
Daiichi Sankyo, - (DSNKY) Japan $43.494B 22.29
BeOne Medicines - (ONC) Cayman Islands $27.892B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.619B 0.00
Merck (MKKGY) Germany $16.901B 12.38
Summit Therapeutics (SMMT) United States $15.834B 0.00
Shionogi (SGIOY) Japan $14.955B 14.98
United Therapeutics (UTHR) United States $12.814B 11.34
Neurocrine Biosciences (NBIX) United States $12.540B 42.95
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.882B 64.08
Stevanato Group S.p.A (STVN) Italy $7.598B 46.46
Madrigal Pharmaceuticals (MDGL) United States $6.650B 0.00
Ionis Pharmaceuticals (IONS) United States $6.331B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.037B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.234B 0.00
Hypermarcas (HYPMY) Brazil $2.914B 19.17
Crinetics Pharmaceuticals (CRNX) United States $2.808B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.670B 9.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.071B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.021B 0.00
Indivior (INDV) United States $1.888B 8.01
ARS Pharmaceuticals (SPRY) United States $1.776B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.742B 0.00
Endo (NDOI) United States $1.603B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.339B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Harrow (HROW) United States $1.150B 0.00
Dyne Therapeutics (DYN) United States $1.142B 0.00
Enliven Therapeutics (ELVN) United States $1.056B 0.00
Verve Therapeutics (VERV) United States $1.003B 0.00
Akebia Therapeutics (AKBA) United States $0.982B 0.00
Collegium Pharmaceutical (COLL) United States $0.961B 5.18
Avadel Pharmaceuticals (AVDL) Ireland $0.899B 0.00
Ardelyx (ARDX) United States $0.882B 0.00
Elite Pharmaceuticals (ELTP) United States $0.780B 0.00
Xeris Biopharma Holdings (XERS) United States $0.741B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xencor (XNCR) United States $0.598B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.579B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.50
KalVista Pharmaceuticals (KALV) United States $0.572B 0.00
Relay Therapeutics (RLAY) United States $0.569B 0.00
AleAnna (ANNA) United States $0.550B 0.00
Bioventus (BVS) United States $0.547B 13.88
Theravance Biopharma (TBPH) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.469B 9.79
Organogenesis (ORGO) United States $0.458B 0.00
Oruka Therapeutics (ORKA) United States $0.435B 0.00
Liminatus Pharma (LIMN) United States $0.432B 0.00
Tourmaline Bio (TRML) United States $0.429B 0.00
Savara (SVRA) United States $0.382B 0.00
Nektar Therapeutics (NKTR) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.06
Heron Therapeutics (HRTX) United States $0.330B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Altimmune (ALT) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.19
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
ProKidney (PROK) United States $0.212B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.206B 0.00
Esperion Therapeutics (ESPR) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.197B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.139B 0.00
Avita Medical (RCEL) United States $0.135B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.100B 16.41
Corbus Pharmaceuticals Holdings (CRBP) United States $0.098B 0.00
Arch Biopartners (ACHFF) Canada $0.091B 0.00
Cassava Sciences (SAVA) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.085B 0.00
Wellgistics Health (WGRX) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.040B 29.78
ElectroCore (ECOR) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Cosmos Health (COSM) United States $0.013B 0.00
Crescent Biopharma (CBIO) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00